Literature DB >> 11456023

Multilayer amniotic membrane transplantation in severe ocular graft versus host disease.

C Peris-Martínez1, J L Menezo, M Díaz-Llopis, J A Aviñó-Martínez, A Navea-Tejerina, P Risueño-Reguillo.   

Abstract

PURPOSE: To clarify the usefulness of multilayer amniotic membrane transplantation in an unusual case of calcareous corneal degeneration in a patient with graft-versus-host disease.
METHODS: A 20-year-old Caucasian woman had bilateral calcareous corneal degeneration of one year of evolution, secondary to graft-versus-host disease. Treatment for both eyes with topical steroids and antibiotic ointment was not successful. Right eye had a spontaneous corneal perforation, and a three-layer circle amniotic membrane graft was applied to the whole cornea.
RESULTS: During a follow-up period of 20 months we observed stability of the corneal epithelium and stroma. The amniotic membrane-covered area showed rapid epithelization, reduced inflammation and suppressed fibrosis formation.
CONCLUSIONS: Multilayer amniotic membrane transplantation may be considered an alterantive for reconstructing the ocular surface in a patient with severe dry eyes and calcareous corneal degeneration, even with little perforation.

Entities:  

Mesh:

Year:  2001        PMID: 11456023     DOI: 10.1177/112067210101100215

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  11 in total

1.  Corneal calcification after amniotic membrane transplantation.

Authors:  S B Anderson; R Ferreira de Souza; C Hofmann-Rummelt; B Seitz
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

Review 2.  Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.

Authors:  Yoshihiro Inamoto; Nuria Valdés-Sanz; Yoko Ogawa; Monica Alves; Luigi Berchicci; John Galvin; Hildegard Greinix; Gregory A Hale; Biljana Horn; Debra Kelly; Hien Liu; Scott Rowley; Helene Schoemans; Ami Shah; Maria Teresa Lupo Stanghellini; Vaibhav Agrawal; Ibrahim Ahmed; Asim Ali; Neel Bhatt; Michael Byrne; Saurabh Chhabra; Zachariah DeFilipp; Kristina Fahnehjelm; Nosha Farhadfar; Erich Horn; Catherine Lee; Sunita Nathan; Olaf Penack; Pinki Prasad; Seth Rotz; Alicia Rovó; Jean Yared; Steven Pavletic; Grzegorz W Basak; Minoo Battiwalla; Rafael Duarte; Bipin N Savani; Mary E D Flowers; Bronwen E Shaw; Igor Petriček
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742

3.  [Ocular graft-versus-host disease].

Authors:  T Dietrich-Ntoukas; P Steven
Journal:  Ophthalmologe       Date:  2015-12       Impact factor: 1.059

4.  Ocular manifestations of graft-versus-host disease.

Authors:  Amr Nassar; Khalid F Tabbara; Mahmoud Aljurf
Journal:  Saudi J Ophthalmol       Date:  2013-07

5.  Refractory recurrent ocular graft versus host disease.

Authors:  Emily Greenan; Elisabeth Vandenberghe; Conor C Murphy
Journal:  BMJ Case Rep       Date:  2019-12-15

6.  Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Authors:  Yoshihiro Inamoto; Nuria Valdés-Sanz; Igor Petriček; Yoko Ogawa; Monica Alves; Luigi Berchicci; John Galvin; Hildegard Greinix; Gregory A Hale; Biljana Horn; Debra Kelly; Hien Liu; Scott Rowley; Helene Schoemans; Ami Shah; Maria Teresa Lupo Stanghellini; Vaibhav Agrawal; Ibrahim Ahmed; Asim Ali; Neel Bhatt; Michael Byrne; Saurabh Chhabra; Zack DeFilipp; Kristina Fahnehjelm; Nosha Farhadfar; Erich Horn; Catherine Lee; Sunita Nathan; Olaf Penack; Pinki Prasad; Seth Rotz; Alicia Rovó; Jean Yared; Steven Pavletic; Grzegorz W Basak; Minoo Battiwalla; Rafael Duarte; Bipin N Savani; Mary E D Flowers; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-12-07       Impact factor: 5.483

7.  Two case reports of continued progression of chronic ocular graft-versus-host disease without concurrent systemic comorbidities treated by amniotic membrane transplantation.

Authors:  Hideto Ikarashi; Naohiko Aketa; Eisuke Shimizu; Yoji Takano; Tetsuya Kawakita; Yuichi Uchino; Yukihiro Matsumoto; Junko Ogawa; Kazuo Tsubota; Yoko Ogawa
Journal:  BMC Ophthalmol       Date:  2021-04-07       Impact factor: 2.209

8.  Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease.

Authors:  Po-Ting Yeh; Yu-Chih Hou; Wei-Chou Lin; I-Jong Wang; Fung-Rong Hu
Journal:  J Formos Med Assoc       Date:  2006-04       Impact factor: 3.282

9.  Self-retained cryopreserved amniotic membrane in treating acute ocular graft-versus-host-disease (oGVHD).

Authors:  Han Y Yin; Swetha Dhanireddy; Robert Weisenthal; Robert Swan; Samuel Alpert; Anny M S Cheng
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-31

Review 10.  Update on ocular graft-versus-host disease.

Authors:  Sridevi Nair; Murugesan Vanathi; Ritika Mukhija; Radhika Tandon; Sandeep Jain; Yoko Ogawa
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.